Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Orient Overseas (International) Ltd
HKEX:316
|
HK |
|
Calibre Mining Corp
TSX:CXB
|
CA |
|
Slater & Gordon Ltd
ASX:SGH
|
AU |
|
Adler Group SA
XETRA:ADJ
|
LU |
|
Centrus Energy Corp
F:4CU
|
US |
Wall St Price Targets
BMRN Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BMRN is 90.91 USD with a low forecast of 50.5 USD and a high forecast of 126 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRN's stock price target?
Price Target
90.91
USD
According to Wall Street analysts, the average 1-year price target for BMRN is 90.91 USD with a low forecast of 50.5 USD and a high forecast of 126 USD.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 3 years is 28%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
60%
The compound annual growth rate for Net Income over the next 3 years is 60%.
